[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100565942":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":34,"responsibleParty":64,"collaborators":66,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":71,"sex":77,"minAge":78,"maxAge":18,"enrollmentInfo":79,"targetDuration":18,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":90,"overallStatus":36,"whyStopped":18,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"University Hospital Muenster","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Prospective patients","EXPERIMENTAL","Current palliative care patients who are discharged from the University Hospital to outpatient palliative care.",[13],"Other: Structured pharmaceutical discharge management",{"label":15,"type":16,"description":17,"interventionNames":18},"Retrospective patients","NO_INTERVENTION","Former palliative care patients who were discharged from the university hospital to outpatient palliative care.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"Structured pharmaceutical discharge management","These patients will receive structured pharmaceutical discharge management from inpatient to outpatient care.",[9],[25],{"name":26,"affiliation":27,"role":28},"Christoph Klaas, Dr. rer. nat.","Pharmacy of the University Hospital Muenster","STUDY_CHAIR",[30],{"name":26,"role":31,"phone":32,"phoneExt":18,"email":33},"CONTACT","+49 251 83-48843","christoph.klaas@ukmuenster.de",[35],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Münster","North Rhine-Westphalia","48149","Germany","DE",{"type":43,"coordinates":44},"Point",[45,46],7.62571,51.96236,{"lat":46,"lon":45},[49,53,55,58,60,62],{"name":50,"role":31,"phone":51,"phoneExt":18,"email":52},"Philipp Lenz, Prof. Dr. med.","+49 (0)251 8353052","philipp.lenz@ukmuenster.de",{"name":26,"role":54,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"name":56,"role":57,"phone":18,"phoneExt":18,"email":18},"Constanze Rémi, Dr. rer. biol. hum.","SUB_INVESTIGATOR",{"name":59,"role":57,"phone":18,"phoneExt":18,"email":18},"Janina Krüger, Dr. med.",{"name":61,"role":57,"phone":18,"phoneExt":18,"email":18},"Sofie May",{"name":63,"role":57,"phone":18,"phoneExt":18,"email":18},"Florian Bernhardt",{"type":65,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[67],{"name":68,"class":6},"University Hospital Munich","100565942","improving-pharmacological-transition-of-palliative-care-patients-from-inpatient-to-outpatient-care-100565942",false,"NCT06648733","Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care","Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care (Optimierung Der Pharmakologischen Überleitung Von Palliativpatient:Innen Von stationär Nach Ambulant)","EntMedPall","Inclusion Criteria:\n\nAll individual indications for general and specialised palliative care as part of routine clinical practice (e.g.):\n\n* advanced, malignant tumour disease\n* advanced, chronic obstructive pulmonary disease\n* Patients with advanced disease and limited life expectancy (approx. 12 months) Further care in the SOPC Muenster (prospective data) Sufficient understanding of the German language to be able to understand the information and consent form\n\nExclusion Criteria:\n\nImpossibility of understanding the information and declaration of consent.","ALL","18 Years",{"count":80,"type":81},200,"ESTIMATED","INTERVENTIONAL",[84],"NA","The transition of palliative care patients from inpatient to outpatient care is aimed to be improved through structured pharmaceutical discharge management by a trained pharmacist. This data will be compared with retrospective cases.",[87,88,89],"Cancer","Heart Failure","COPD",[91],"Palliative Care","2025-06-10",{"date":94,"type":95},"2025-06-13","ACTUAL",{"date":97,"type":95},"2024-06-20",{"date":99,"type":81},"2025-12-31",{"name":5,"class":6},1]